ALLOAllogene Therapeutics, Inc.
$1.40+3.7% 1Y
$1.40
$1.0552 weeks$3.06
Is the price fair?
What ALLO's price assumes
- Price / book
- 3.02
Price / book · as of 2026-Q1
Details›
- Price / bookas of 2026-Q1
- 3.02
- EV / EBIToperating margin −2636%: the multiple describes the denominator
- not meaningful
- Market capitalisation
- $483M
Multiples from SEC filings and end-of-day closes; implied growth from a reverse discounted cash flow. Group medians across the names Ryufin tracks.